The TSX Venture Exchange has accepted for filing documentation relating to a merger agreement, which became effective on March 30, 2025, between Vitalist Inc. and Somatix Inc.

On April 30, 2026, the company acquired 100 per cent of the issued and outstanding shares of the vendor. As consideration for the acquisition, the company issued 15,581,854 common shares of the company at a deemed issue price 79 cents, representing the total consideration of approximately $12,309,664. A total of 12.5 per cent of the consideration shares have been deposited into escrow with Endeavor Trust Corp. for a period of 18 months to secure certain indemnification obligations of the former Somatix shareholders.

Additionally, certain former significant Somatix shareholders have entered into lock-up agreements with the company restricting the resale of their consideration shares, with 25 per cent to be released after 12 months, 25 per cent after 18 months and the remaining 50 per cent after 24 months, in each case following closing.

For further details, please refer to the company's news releases dated March 31, 2026, and April 30, 2026.